(Q40858120)

24 September 2017

1 reference

title

Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome (English)

1 reference

24 September 2017

Guillain–Barré syndrome

0 references

1 reference

Zhu J

1

1 reference

PubMed ID

9600707

24 September 2017

Mix E

series ordinal

2

1 reference

PubMed ID

9600707

24 September 2017

Link H

series ordinal

3

1 reference

24 September 2017

1 April 1998

1 reference

Journal of Neuroimmunology

24 September 2017

1 reference

24 September 2017

84

1 reference

24 September 2017

1

1 reference

24 September 2017

40-52

1 reference

Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Pathogenesis and immunotherapy of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Effects of zimeldine and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interleukin-6 production by Schwann cells and induction in sciatic nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Tumour necrosis factor-alpha and other cytokines in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Genetic control of susceptibility to experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Effect of transforming growth factor-beta 1 and -beta 2 on Schwann cell proliferation on neurites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Activated T lymphocyte subsets in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Autoimmune responses in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Identification of the neuritogen for experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Th1 and Th2 subsets: paradigms lost?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

T cell responses to myelin proteins in Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Complexities in the treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

P0 myelin protein produces experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Effect of ion channel blockers on immune response and course of experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

New minimum length requirement for a T cell epitope for experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Understanding the role of Th1/Th2 cells in infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Guillain-Barré syndrome: clinical and immunological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Nerve lesions induced by macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Intraneural activated T cells cause focal breakdown of the blood-nerve barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

In vivotreatment of rats with monoclonal antibodies against gamma interferon: effects on experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Interferon-gamma inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression of Schwann cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Oral administration of type I interferon modulates the course of experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Cytokines and the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Dynamics of mRNA expression of interferon-γ, interleukin 4 and transforming growth factor β1 in sciatic nerves and lymphoid organs in experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900238-5

7 January 2021

10.1016/S0165-5728(97)00238-5

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9600707